EG231836 Activators
Kif19b, a member of the kinesin family, intricately regulates cellular processes through its predicted functions in ATP hydrolysis, microtubule binding, and plus-end-directed microtubule motor activity. Its pivotal role in microtubule-based movement positions Kif19b as a key player in cellular dynamics. Activation of Kif19b involves a complex interplay of various signaling pathways and molecular interactions. The modulation of microtubule dynamics emerges as a central theme in Kif19b activation, with chemicals influencing stability, polymerization, or depolymerization impacting its plus-end-directed motor activity.
Paclitaxel, for instance, enhances microtubule stability, indirectly promoting Kif19b engagement in microtubule-based movement. Similarly, compounds like Nocodazole, acting as microtubule depolymerizing agents, induce Kif19b activation by influencing microtubule disassembly. Furthermore, Kif19b's interaction with cell cycle-associated pathways, exemplified by Plk1 inhibition, adds an additional layer of complexity to its regulation. The multifaceted nature of Kif19b activation showcases its adaptability in responding to cellular cues, highlighting its significance in maintaining cellular homeostasis. Understanding these intricate mechanisms not only deepens our insight into Kif19b's cellular functions but also provides avenues for targeted modulation in scientific investigations.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel, a microtubule-stabilizing agent, promotes Kif19b activation by enhancing microtubule stability. Its binding to microtubules increases their polymerization, indirectly facilitating the engagement of Kif19b as a plus-end-directed microtubule motor. | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
Monastrol, a kinesin Eg5 inhibitor, induces Kif19b activation by disrupting the balance of opposing kinesins. By inhibiting Eg5, it leads to altered microtubule dynamics, indirectly favoring Kif19b's engagement in microtubule-based movement. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Epothilone B, a microtubule stabilizer, indirectly activates Kif19b by stabilizing microtubules. The enhanced microtubule structure provides an optimal substrate for Kif19b, facilitating its plus-end-directed motor activity in microtubule-based movement. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI2536, a Plk1 inhibitor, influences Kif19b activation by modulating the Plk1 pathway. Plk1 inhibition alters microtubule dynamics, indirectly affecting Kif19b's plus-end-directed motor activity, emphasizing the intricate relationship between Kif19b and cell cycle-associated pathways. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, a microtubule depolymerizing agent, activates Kif19b by inducing microtubule disassembly. This disruption promotes Kif19b engagement in microtubule-based movement, highlighting the sensitivity of Kif19b activity to the structural dynamics of the microtubule network. | ||||||
Trifluorothymidine | 70-00-8 | sc-222370 sc-222370A | 100 mg 1 g | $179.00 $500.00 | 1 | |
Trifluorothymidine activates Kif19b by promoting microtubule stability. Its incorporation into growing microtubule ends enhances stability, indirectly supporting Kif19b's plus-end-directed motor activity in microtubule-based movement, revealing the regulatory influence of nucleoside analogs. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666, an Arp2/3 complex inhibitor, influences Kif19b activation by modulating the actin cytoskeleton. By disrupting Arp2/3-mediated actin dynamics, it indirectly impacts Kif19b's ability to engage in microtubule-based movement, revealing the intricate interplay between actin and microtubule networks. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, activates Kif19b by modulating calcium-dependent signaling pathways. Calcium influx influences microtubule dynamics, indirectly promoting Kif19b's plus-end-directed motor activity in microtubule-based movement, illustrating the role of ionophores in cellular regulation. | ||||||
Noscapine | 128-62-1 | sc-219418 | 10 mg | $102.00 | ||
Noscapine, a microtubule-targeting agent, promotes Kif19b activation by influencing microtubule dynamics. Its interactions with microtubules indirectly facilitate Kif19b's plus-end-directed motor activity in microtubule-based movement, revealing the potential of alkaloids in regulating cellular processes. | ||||||
CK-689 | 170930-46-8 | sc-507371 | 25 mg | $312.00 | ||
CK-689, a Rho-associated kinase (ROCK) inhibitor, influences Kif19b activation by modulating the Rho/ROCK pathway. ROCK inhibition alters actin dynamics, indirectly affecting Kif19b's engagement in microtubule-based movement, highlighting the interplay between the Rho/ROCK pathway and Kif19b regulation. | ||||||